DAX23.335 +1,1%ESt505.283 ±-0,0%Top 10 Crypto12,53 +0,6%Dow41.427 +0,3%Nas17.893 -0,5%Bitcoin83.154 -0,2%Euro1,1301 ±-0,0%Öl60,03 -2,3%Gold3.307 +2,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 BASF BASF11 RENK RENK73 Berkshire Hathaway A0YJQ2 Novo Nordisk A3EU6F Lufthansa 823212 Allianz 840400 Mercedes-Benz Group (ex Daimler) 710000 Siemens Energy ENER6Y Tesla A1CX3T BP 850517 Deutsche Bank 514000 HENSOLDT HAG000 Amazon 906866
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX beendet Handel im Plus -- Berkshire mit Gewinnrückgang - Buffett will aufhören -- BYD steigert Absatz im April -- Shell, BP, D-Wave, BioNTech, NVIDIA, Rheinmetall, SAP im Fokus
Top News
Auf dem Verkaufszettel: Diese Aktien empfehlen Experten zu verkaufen Auf dem Verkaufszettel: Diese Aktien empfehlen Experten zu verkaufen
Lufthansa-Aktie zieht an: Gruppe stoppt Flüge von und nach Tel Aviv - Hauptversammlung am Dienstag Lufthansa-Aktie zieht an: Gruppe stoppt Flüge von und nach Tel Aviv - Hauptversammlung am Dienstag
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

AstraZeneca Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
126,90 EUR +1,00 EUR +0,79 %
FSE
117,88 CHF -1,82 CHF -1,52 %
BRX
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.195,59 Mrd. EUR

KGV29,47Div. Rendite2,35%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN886455

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINGB0009895292

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolAZNCF

AstraZeneca Aktien News

DatumMeistgelesen
ZacksThe Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes
ZacksTop Analyst Reports for AstraZeneca, QUALCOMM & FedEx
PR NewswireAbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PR NewswireAlexion Canada Raises Awareness for Rare Diseases Through International colourUp4RARE Campaign
PR NewswireAlexion Canada Raises Awareness for Rare Diseases Through International colourUp4RARE Campaign
PR NewswireSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
PR NewswireSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
PR NewswireSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
PR NewswireSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
PR NewswireCompugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
PR NewswireAllorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
PR NewswireAllorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
PR NewswireAllorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
PR NewswireAllorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
PR NewswireCompugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
PR NewswireKoselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas
PR NewswirePresage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO® Technology
PR NewswireHealth Canada approves Ultomiris for adults with neuromyelitis optica spectrum disorder (NMOSD)
PR NewswireHealth Canada approves Ultomiris for adults with neuromyelitis optica spectrum disorder (NMOSD)
PR NewswireAlexion, AstraZeneca Rare Disease, concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of patients with paroxysmal nocturnal hemog...
PR NewswireAlexion, AstraZeneca Rare Disease, concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of patients with paroxysmal nocturnal hemog...
PR NewswireSOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
PR NewswireSOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
PR NewswireSOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
PR NewswireSOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
PR NewswireFusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers
PR NewswireFusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers
PR NewswireASTRAZENECA AND INSTITUT KANSER NEGARA PARTNER TO INTRODUCE AI TECHNOLOGY FOR LUNG SCREENING
PR NewswireShanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting
PR NewswireShanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting
PR NewswireShanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting
PR NewswireShanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting
PR NewswireNew analysis of Phase II data at AACR assesses ImaginAb's investigational CD8 ImmunoPET technology's ability to predict response in immunotherapy
PR NewswireFusion Pharmaceuticals Announces IND Clearance for FPI-2068, a Jointly Developed Novel Targeted Alpha Therapy
PR NewswireFusion Pharmaceuticals Announces IND Clearance for FPI-2068, a Jointly Developed Novel Targeted Alpha Therapy
PR NewswireAstraZeneca Thailand Wins Two ACES Awards 2022: "Industry Champions of the Year" and "Community Initiative"
PR NewswireInvitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research
PR NewswireHONEYWELL BEGINS PRODUCTION OF NEAR-ZERO GLOBAL-WARMING-POTENTIAL MEDICAL PROPELLANT
PR NewswireBaili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 bispecific Antibody, in Combination with Tagrisso® in Patients with Non-Small Cell Lung Cancer
Wer­bung

AstraZeneca News

AstraZeneca News: auf dieser Seite finden Sie alle AstraZeneca News und Nachrichten zur AstraZeneca Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AstraZeneca News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AstraZeneca News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.